22-40861553-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145174.2(DNAJB7):āc.442G>Cā(p.Glu148Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145174.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB7 | NM_145174.2 | c.442G>C | p.Glu148Gln | missense_variant | 1/1 | ENST00000307221.5 | NP_660157.1 | |
XPNPEP3 | NM_022098.4 | c.64+4308C>G | intron_variant | ENST00000357137.9 | NP_071381.1 | |||
XPNPEP3 | NM_001204827.2 | c.*13-65C>G | intron_variant | NP_001191756.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249406Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134786
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460916Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726694
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2024 | The c.442G>C (p.E148Q) alteration is located in exon 1 (coding exon 1) of the DNAJB7 gene. This alteration results from a G to C substitution at nucleotide position 442, causing the glutamic acid (E) at amino acid position 148 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at